Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine in the treatment of psychotic depression (pilot study)
2008-000041-60Phase 3Active
- Sponsor
- LWL University Hospital Bochum
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of quetiapine in major depressive disorder (MDD), sponsored by LWL University Hospital Bochum. Primary endpoint: Change in MADRS total score from baseline to week 6 (LOCF). Started Mar 2008; status: active.
02
Drugs
quetiapine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2008-000041-60.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000041-60.